Androgen insensitivity syndrome CT
Jump to navigation
Jump to search
|
Androgen insensitivity syndrome Microchapters |
|
Differentiating Androgen insensitivity syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Androgen insensitivity syndrome CT On the Web |
|
American Roentgen Ray Society Images of Androgen insensitivity syndrome CT |
|
Directions to Hospitals Treating Androgen insensitivity syndrome |
|
Risk calculators and risk factors for Androgen insensitivity syndrome CT |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
Findings of seminoma are observed by FDG PET/CT in androgen insensitivity syndrome. Detection of sertoli-Leydig cell tumor accidentally is by FDG-PET/CT imaging.
CT
- FDG-PET/CT findings are observed of seminoma in androgen insensitivity syndrome.[1]
- PET images showed focal FDG uptake in the left pelvic sidewall, and a hypodense lesion with calcifications was noted in the corresponding CT images.
- Another smaller hypodense lesion with calcifications was noted in the right pelvic sidewall, but faint FDG uptake.
- Detection of sertoli-Leydig cell tumor accidentally is by FDG-PET/CT imaging. An F-18 fluorodeoxyglucose PET study, and a pathologically increased FDG uptake at the left lower abdomen was detected corresponding to a solid, cystic lesion on CT images. [2]
References
- ↑ Han EJ, O JH, Park G, Lee J (2017). "FDG PET/CT Image of Seminoma in Androgen Insensitivity Syndrome". Clin Nucl Med. 42 (8): e381–e382. doi:10.1097/RLU.0000000000001722. PMID 28604478.
- ↑ Ozülker T, Ozpaçaci T, Ozülker F, Ozekici U, Bilgiç R, Mert M (2010). "Incidental detection of Sertoli-Leydig cell tumor by FDG PET/CT imaging in a patient with androgen insensitivity syndrome". Ann Nucl Med. 24 (1): 35–9. doi:10.1007/s12149-009-0321-x. PMID 19957213.